Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J P Fitzgerald

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Leukemia & Lymphoma|October 10, 2009
Approach to the patient after relapse of hairy cell leukemiaRobert J Kreitman, David J P Fitzgerald, Ira Pastan
The Medical Journal of Australia|October 20, 2010
Insulin-dependent diabetes and aeromedical certification - the Australian perspectiveDavid J P Fitzgerald, Pooshan D Navathe, A Michael Drane
Aviation, Space, and Environmental Medicine|May 28, 2011
Aeromedical decision making in attention-deficit/hyperactivity disorderDavid J P Fitzgerald, Pooshan D Navathe, A Michael Drane
Leukemia & Lymphoma|May 24, 2011
Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemiaRobert J Kreitman, Evgeny Arons, Maryalice Stetler-Stevenson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2009
Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemiaRobert J Kreitman, Maryalice Stetler-Stevenson, Inger Margulies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2005
Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignanciesRobert J Kreitman, David R Squires, Maryalice Stetler-Stevenson, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Leukemia & Lymphoma|October 10, 2009
Approach to the patient after relapse of hairy cell leukemiaRobert J Kreitman, David J P Fitzgerald, Ira Pastan
The Medical Journal of Australia|October 20, 2010
Insulin-dependent diabetes and aeromedical certification - the Australian perspectiveDavid J P Fitzgerald, Pooshan D Navathe, A Michael Drane
Aviation, Space, and Environmental Medicine|May 28, 2011
Aeromedical decision making in attention-deficit/hyperactivity disorderDavid J P Fitzgerald, Pooshan D Navathe, A Michael Drane
Leukemia & Lymphoma|May 24, 2011
Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemiaRobert J Kreitman, Evgeny Arons, Maryalice Stetler-Stevenson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2009
Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemiaRobert J Kreitman, Maryalice Stetler-Stevenson, Inger Margulies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2005
Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignanciesRobert J Kreitman, David R Squires, Maryalice Stetler-Stevenson, et al.
Pageof 1